Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Offerpad Solutions
OPAD
$18.5M
| $47.9K | ﹤0.01% |
1,148
-133
| -10% | -$3.65K |
|
4677
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
| $47.6K | ﹤0.01% |
430
| – | – |
|
4678
MDxHealth
MDXH
$20.6M
| $46.8K | ﹤0.01% |
+10,060
| New | +$30.9K |
|
4679
Liberty Broadband Class A
LBRDA
$4.89B
| $46.3K | ﹤0.01% |
731
-3,412
| -82% | -$237K |
|
4680
ProShares Ultra Gold
UGL
$649M
| $46.1K | ﹤0.01% |
1,000
-860
| -46% | -$32.4K |
|
4681
Bausch Health
BHC
$1.75B
| $45.7K | ﹤0.01% |
7,090
-54,318
| -88% | -$371K |
|
|
ZONE
4682
CleanCore Solutions
ZONE
$71.8M
| $45.7K | ﹤0.01% |
+22,637
| New | +$81.2K |
|
|
USAS
4683
Americas Gold and Silver
USAS
$1.24B
| $45.2K | ﹤0.01% |
+12,160
| New | +$31.8K |
|
4684
iShares Core US Aggregate Bond ETF
AGG
$138B
| $45.1K | ﹤0.01% |
450
-7,451
| -94% | -$739K |
|
4685
StealthGas
GASS
$326M
| $44.9K | ﹤0.01% |
6,853
+4,684
| +216% | +$32.5K |
|
4686
Tevogen Bio Holdings
TVGN
$25.1M
| $44.8K | ﹤0.01% |
1,141
-231
| -17% | -$11.4K |
|
4687
Open Text
OTEX
$6.28B
| $44.6K | ﹤0.01% |
1,192
-1,967
| -62% | -$63.1K |
|
4688
Invesco BuyBack Achievers ETF
PKW
$1.72B
| $44.5K | ﹤0.01% |
336
| – | – |
|
4689
Cemex
CX
$16.9B
| $44.4K | ﹤0.01% |
4,944
-123,537
| -96% | -$1.05M |
|
4690
Value Line
VALU
$333M
| $44.2K | ﹤0.01% |
1,132
-217
| -16% | -$8.3K |
|
4691
Sagimet Biosciences
SGMT
$435M
| $44K | ﹤0.01% |
+6,409
| New | +$52K |
|
|
DEFT
4692
Defi Technologies
DEFT
$151M
| $43.9K | ﹤0.01% |
20,811
-43,190
| -67% | -$112K |
|
4693
BRC Group Holdings
RILY
$264M
| $43.8K | ﹤0.01% |
7,335
+5,658
| +337% | +$31.3K |
|
4694
Schneider National
SNDR
$6.17B
| $43.8K | ﹤0.01% |
2,070
-12,952
| -86% | -$317K |
|
4695
Lexicon Pharmaceuticals
LXRX
$1.03B
| $43K | ﹤0.01% |
31,862
-408
| -1% | -$463 |
|
4696
Global X Data Center & Digital Infrastructure ETF
DTCR
$2.03B
| $43K | ﹤0.01% |
2,100
| – | – |
|
|
WW
4697
WW International
WW
$130M
| $42.9K | ﹤0.01% |
+1,569
| New | +$53.9K |
|
4698
CALL
Wolfspeed
WOLF
$1.04B
| $42.9K | ﹤0.01% |
+1,500
| New | +$3.52K |
|
4699
HUTCHMED
HCM
$1.96B
| $42.8K | ﹤0.01% |
2,720
+278
| +11% | +$4.58K |
|
|
NYAX
4700
Nayax
NYAX
$2.54B
| $42.5K | ﹤0.01% |
893
-2,099
| -70% | -$97.6K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.